AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
NASDAQ · Healthcare · Biotechnology · CN
$17.62
+1.47%Margins
Gross margin
85.1%
EBITDA margin
-228.8%
EBIT margin
-244.8%
Net margin
-254.7%
FCF margin
-157.9%
-468.4%
Return on equity
-80.4%
Return on assets
-94.5%
Return on invested capital
0.28x
Asset turnover
-$233.9M
Cash from operations
$3.03
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026